Search results
Results from the WOW.Com Content Network
Vitiligo (/ ˌ v ɪ t ɪ ˈ l aɪ ɡ oʊ /, vi-ti-leye-goh) is a chronic autoimmune disorder that causes patches of skin to lose pigment or color. [1] The cause of vitiligo is unknown, but it may be related to immune system changes, genetic factors, stress, or sun exposure. [5] [6] Treatment options include topical medications, light therapy ...
Nevus depigmentosus is a loss of pigment in the skin which can be easily differentiated from vitiligo. Although age factor has not much involvement in the nevus depigmentosus but in about 19% of the cases these are noted at birth. Their size may however grow in proportion to growth of the body.
Darkening depigmented skin is also extremely difficult. [26] Depigmentation causes a permanent and extreme sensitivity to the sun. [27] Vitiligo patients are at risk to contract melanoma, and an annual cancer check-up is recommended. [28] Jackson also covered his skin disorder with clothing wearing long sleeves and long pants.
For premium support please call: 800-290-4726 more ways to reach us
Skin pigmentation is frequently caused by sun exposure. To protect itself against UV radiation from the sun, the body makes more melanin. As a result, the skin may become more pigmented to protect it from the sun's rays. [4] The pigmentation of the skin may also be lightened by certain drugs.
Michael was diagnosed with vitiligo in 1983. The 13-time Grammy winner used fair-colored makeup and creams to cover the blotches, causing a very pale appearance.
Depigmentation is the lightening of the skin or loss of pigment. Depigmentation of the skin can be caused by a number of local and systemic conditions. The pigment loss can be partial (injury to the skin) or complete (caused by vitiligo). It can be temporary (from tinea versicolor) or permanent (from albinism). [1]
PUVA (psoralen and UVA) is an ultraviolet light therapy treatment for skin diseases: vitiligo, eczema, psoriasis, graft-versus-host disease, mycosis fungoides, large plaque parapsoriasis, and cutaneous T-cell lymphoma, using the sensitizing effects of the drug psoralen.